Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogene

Laboratory Investigation

Volumn 76, Issue 3, 1997, Pages 307-318

  Sagartz, John E ^a   Jhiang, Sissy M ^a   Tong, Qiang ^a   Capen, Charles C ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Veterinary Biosciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; THYROID HORMONE; THYROTROPIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; HORMONE RESPONSE; MALE; NONHUMAN; ONCOGENE RET; PRIORITY JOURNAL; SPINDLE CELL; THYROID CARCINOMA; THYROID HORMONE RELEASE; THYROID WEIGHT; THYROTROPIN RELEASE; TRANSGENIC MOUSE; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ANIMALS; CATTLE; DROSOPHILA PROTEINS; FEMALE; HUMANS; HYPERPLASIA; IODINE; MALE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; ONCOGENES; PITUITARY GLAND; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; SEX CHARACTERISTICS; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE;

EID: 0031006554     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bartalena L, Martino E, Pacchiarotti A, Grasso L, Aghini-Lombardi F, Buratti L, Bambini G, Breccia M, and Pinchera A (1987). Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: Retrospective analysis in athyreotic and goitrous patients. J Clin Endocrinol Metab 64:849-855.
2. Baverstock KF (1993). Thyroid cancer in children in Belarus after Chernobyl. World Health Stat Q 46:204-208.
3. Bond JA, Wyllie FS, Rowson J, Radulescu A, and Wynford-Thomas D (1994). In vitro reconstruction of tumour initiation in a human epithelium. Oncogene 9:281-290.
4. Capen CC (1990). Tumors of the endocrine glands. In: Moulton J, editor. Tumors in domestic animals. Los Angeles: University of California Press, 553-639.
5. Capen CC, DeLellis RA, and Yarrington JT (1991). Endocrine system. In: Haschek WM, Rousseaux CG, editors. Fundamentals of toxicologic pathology. New York: Academic Press, 675-760.
6. Crile G (1966). Endocrine dependency of papillary carcinomas of the thyroid. J Am Med Assoc 195:101-104.
7. Culter SJ and Yound JL (1975). Third national cancer survey incidence data. In: National Cancer Institute, Monograph No 41. Washington DC: Department of Health Education and Welfare, 755-787.
8. Delange F and Ermans A-M (1991). Iodine deficiency. In: Braverman LE and Utiger RD, editors. Werner and Ingbar's the thyroid: A fundamental and clinical text. Philadelphia: JB Lippincott, 368-390.
9. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fékété, Ponder BAJ, and Munnich A (1994). Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367:378-380.
10. Emerick GT, Duh Q-Y, Siperstein AE, Burrow GN, and Clark OH (1993). Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 72:3287-3295.
11. Farid NR, Shi Y, and Zou M (1994). Molecular basis of thyroid cancer. Endocr Rev 15:202-232.
12. Filetti S, Belfiore A, Amir SM, Daniels GH, Ippolito O, Vigneri R, and Ingbar SH (1988). The role of thyroid stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med 318:758-759.
13. Fjälling M, Tisell L-E, Carlsson S, Hansson G, Lundberg L-M, and Odén A (1986). Benign and malignant thyroid nodules after neck irradiation. Cancer 58:1219-1224.
14. Fortner JG, George PA, and Sternberg SS (1960). Induced and spontaneous thyroid cancer in the syrian (golden) hamster. Endocrinology 66:364-376.
15. Furmanchuk AW, Averkin JI, Egloff B, Ruchti C, Abelin T, Schäppi W, and Korotkevich EA (1992). Pathomorphological findings in thyroid cancers of children from the Republic of Belarus: A study of 86 cases occurring between 1986 ('post-Chernobyl') and 1991. Histopathology 21:401-408.
16. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JWM, van Amstel HKP, Romeo G, Lips CJM, and Buys CHCM (1994). A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376.
17. Holm R and Nesland JM (1994). Retinoblastoma and p53 tumors suppressor gene protein expression in carcinomas of the thyroid gland. J Pathol 172:267-272.
18. Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N, and Akiyama M (1993a). In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res 53:2940-2943.
19. Ito T, Seyama T, Mizuno T, Tsuyama N, Hayashi T, Dohi K, Nakamura N, and Akiyama M (1993b). Genetic alterations in thyroid tumor progression: Association with p53 gene mutations. Jpn J Cancer Res 84:526-531.
20. Jhiang SM, Caruso DR, Gilmore E, Ishizaka Y, Tahira T, Nagao M, Chiu I-M, and Mazzaferri EL (1992). Detection of the PTC/ret oncogene in human thyroid cancers. Oncogene 7:1331-1337.
21. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho J-Y, Xing S, and Ledent C (1996). Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137:375-378.
22. Kobayashi K, Tanaka Y, Ishiguro S, and Mori T (1994). Rapidly growing thyroid carcinoma during pregnancy. J Surg Oncol 55:61-64.
23. Matias-Guiu X, Cuatrecasas M, Musulen E, and Prat J (1994). p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas. J Clin Pathol 47:337-339.
24. Mazzaferri EL (1988). Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 14:315-332.
25. Mazzaferri EL and Jhiang SM (1994). Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid carcinoma. Am J Med 97:418-428.
26. Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, and Page CP (1977). Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine 56:171-196.
27. Nikiforov Y and Gnepp DR (1994). Pediatric thyroid cancer after the Chernobyl disaster: Pathomorphologic study of 84 cases (1991-1992) from the republic of Belarus. Cancer 74:748-766.
28. Nishiyama RH, Dunn EL, and Thompson NW (1972). Anaplastic spindle-cell and giant-cell tumors of the thyroid gland. Cancer 30:113-127.
29. Peterson ME, Graves TK, and Cavanagh I (1987). Serum thyroid hormone concentrations fluctuate in cats with hyperthyroidism. J Vet Intern Med 1:142-146.
30. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kääriäinen H, and Martucciello G (1994). Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367:377-378.
31. Rosai J, Carcangiu ML, and DeLellis RA (1990). Tumors of the thyroid gland. In: Rosai J and Sobin LH, editors: Atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology.
32. Sagartz JE, Bodley WL, Gamblin RM, Couto CG, Tierney LA, and Capen CC (1996). p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Vet Pathol 33:213-221.
33. Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, della Porta G, Berger N, Peix JL, Paulin C, Fabien N, Vecchio G, Jenkins RB, and Fusco A (1992). Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89:1517-1522.
34. Santoro M, Rosati R, Grieco M, Berlingieri MT, D'Amato GL-C, di Franciscis V, and Fusco A (1990). The ret protooncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5:1595-1598.
35. Scanlon MF (1991). Neuroendocrine control of thyrotropin secretion. In: Braverman LE and Utiger RD, editors. Werner and Ingbar's the thyroid: A fundamental and clinical text. Philadelphia: JB Lippincott, 230-256.
36. Slye M, Holmes HF, and Wells HG (1926). Studies in the incidence and inheritability of spontaneous thyroid tumours in mice: XXII - The comparative pathology of cancer of the thyroid with report of primary spontaneous tumours of the thyroid in mice and in a rat. Cancer Res 10:175-194.
37. Taniguchi M, Iwamoto T, Hamaguchi M, Matsuyama M, and Takahashi M (1991). The RET oncogene products are membrane-bound glycoproteins phosphorylated on tyrosine residues in vivo. Biochem Biophys Res Commun 181:416-422.
38. Thomas GA and Williams ED (1991). Evidence for and possible mechanisms of non-genotoxic carcinogenesis in the rodent thyroid. Mutat Res 248:357-370.
39. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, and Rosenthal A (1996). Characterization of a multicomponenet receptor for GDNF. Nature 382:80-83.
40. Ueda G and Furth J (1967). Sarcomatoid transformation of transplanted thyroid carcinoma. Similarity to anaplastic human thyroid carcinomas. Arch Pathol 83:3-12.
41. Vander J (1968). The significance of nontoxic thyroid nodules: A 15-year study on the incidence of thyroid malignancy. Ann Intern Med 69:537-540.
42. Wajjwalku W, Nakamura S, Hasegawa Y, Miyazaki K, Satoh Y, Funahashi H, Matsuyama M, and Takahashi M (1992). Low frequency of rearrangements of the ret and trk protooncogenes in Japanese thyroid papillary carcinomas. Jpn J Cancer Res 83:671-675.
43. Wingren G, Hatschek T, and Axelson O (1993). Determinants of papillary cancer of the thyroid. Am J Epidemiol 138:482-491.
44. Wynford-Thomas D, Stringer BMJ, and Williams ED (1982). Dissociation of growth and function in the rat thyroid during prolonged goitrogen administration. Acta Endocrinol 101: 210-216.
45. TPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer 73:176-180.